Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IMMX

Immix Biopharma Inc

Jun 18 • 04:00PM ET

8.72

-0.41 -4.49 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY KYMR NUVL BMRN RYTM VKTX KRYS AXSM MDGL NBIX

| Held by: VTI VXF IWC LABU BBC TNXT PWS AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	23.49%	Shs Outstand	71.19M	Perf Week	7.65%
Market Cap	620.78M	Forward P/E	-	EPS next Y	-0.74	Insider Trans	0.00%	Shs Float	54.47M	Perf Month	-1.58%
Enterprise Value	531.24M	PEG	-	EPS next Q	-0.17	Inst Own	43.58%	Short Float	7.40%	Perf Quarter	-9.92%
Income	-34.98M	P/S	-	EPS this Y	22.28%	Inst Trans	10.43%	Short Ratio	3.76	Perf Half Y	46.80%
Sales	0.00M	P/B	5.48	EPS next Y	-7.23%	ROA	-60.47%	Short Interest	4.03M	Perf YTD	66.73%
Book/sh	1.59	P/C	6.85	EPS next 5Y	24.70%	ROE	-74.47%	52W High	11.61 -24.89%	Perf Year	264.85%
Cash/sh	1.27	P/FCF	-	EPS past 3/5Y	-12.81% -43.32%	ROIC	-41.02%	52W Low	1.94 349.48%	Perf 3Y	292.79%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.74% 8.88%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-27.17%	Oper. Margin	-	ATR (14)	0.75	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.76	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.50	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.76	EPS Q/Q	-19.16%	SMA20	2.04%	Beta	0.11	Target Price	19.79
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-5.49%	Rel Volume	6.92	Prev Close	9.13
Employees	21	LT Debt/Eq	0.01	Earnings	Jun 03	SMA200	38.51%	Avg Volume	1.07M	Price	8.72
IPO	Dec 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.11% -	Trades		Volume	7,413,075	Change	-4.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)